MAPT and Alzheimer disease: An important line of evidence for a central role of cholesterol in neurodegeneration was the discovery of the APOE4 allele as the strongest genetic risk factor for late onset AD (Corder et al., 1993), with modulatory effects on tau pathology and tau-related neurodegeneration (Shi et al., 2017).